pR26 GFP Dest Citations (4)

Originally described in: Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.
Chu VT, Weber T, Graf R, Sommermann T, Petsch K, Sack U, Volchkov P, Rajewsky K, Kuhn R BMC Biotechnol. 2016 Jan 16;16(1):4. doi: 10.1186/s12896-016-0234-4. PubMed Journal

---

Articles Citing pR26 GFP Dest

Articles
Pituitary Tumors and Immortalized Cell Lines Generated by Cre-Inducible Expression of SV40 T Antigen. Daly AZ, Mortensen AH, Bando H, Camper SA. Endocrinology. 2021 Jul 1;162(7). pii: 6219492. doi: 10.1210/endocr/bqab073. PubMed
RNA-targeted therapy corrects neuronal deficits in PACS1 syndrome mice. Thomas G, Villar-Pazos S, Thomas L, Yang Y, Chen K, Lyles J, Deitch B, Ochaba J, Ling K, Powers B, Gingras S, Kordasiewicz H, Grubisha M, Huang Y. Res Sq. 2023 Jan 27:rs.3.rs-2440581. doi: 10.21203/rs.3.rs-2440581/v1. Preprint. PubMed
Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy. Villar-Pazos S, Thomas L, Yang Y, Chen K, Lyles JB, Deitch BJ, Ochaba J, Ling K, Powers B, Gingras S, Kordasiewicz HB, Grubisha MJ, Huang YH, Thomas G. Nat Commun. 2023 Oct 17;14(1):6547. doi: 10.1038/s41467-023-42176-8. PubMed
Inactivation of the PHD3-FOXO3 axis blunts the type I interferon response in microglia and ameliorates Alzheimer's disease progression. Sanchez-Garcia MA, Lara-Urena N, March-Diaz R, Ortega-de San Luis C, Quinones-Canete S, Mora-Romero B, Barba-Reyes JM, Cabello-Rivera D, Romero-Molina C, Heras-Garvin A, Navarro V, Lopez-Barneo J, Vizuete M, Vitorica J, Munoz-Cabello AM, Munoz-Manchado AB, Cokman ME, Rosales-Nieves AE, Pascual A. Sci Adv. 2025 May 30;11(22):eadu2244. doi: 10.1126/sciadv.adu2244. Epub 2025 May 28. PubMed

If you have published an article using this material, please email us at to have your article added to this page.